Deerfield Management’s AbbVie ABBV Stock Holding History

Deerfield Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,014	Closed	-$460K	–	83
2025 Q4	$460K	Buy	+2,014	New	+$459K	0.01%	131
2015 Q2	–	Sell	-1,534,000	Closed	-$89.8M	–	121
2015 Q1	$89.8M	Buy	+1,534,000	New	+$92.7M	2.91%	4
2014 Q4	–	Sell	-766,400	Closed	-$44.3M	–	112
2014 Q3	$44.3M	Buy	766,400 +225,000	+42%	+$12.5M	1.61%	22
2014 Q2	$30.6M	Sell	541,400 -483,600	-47%	-$25.4M	1.23%	25
2014 Q1	$52.7M	Buy	+1,025,000	New	+$51.8M	2.15%	13
2013 Q4	–	Sell	-1,005,000	Closed	-$45M	–	107
2013 Q3	$45M	Buy	1,005,000 +388,000	+63%	+$17.2M	2.09%	10
2013 Q2	$25.5M	Buy	+617,000	New	+$27M	1.2%	34

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management's ABBV Position: Q1 2026 in Review

Deerfield Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 2,014 shares — an estimated $460K sold.

Deerfield Management first reported a position in ABBV in Q2 2013 and held it in 7 quarters. The position peaked at $89.8M in Q1 2015. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Deerfield Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Deerfield Management sold 2,014 AbbVie shares in Q1 2026, an estimated $460K.
Deerfield Management first reported a position in AbbVie in Q2 2013 and held it in 7 quarters.
Deerfield Management's AbbVie position peaked at $89.8M in Q1 2015.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.